exe844
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Jun 1, 2015 (NCT02436304)
Timeline
Indications
Mechanism of action
- Replicase polyprotein 1abINHIBITOR
rep inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- exe844
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02539654 | Phase 1 | Nov 1, 2015 | Alcon |
| NCT02432105 | Phase 3 | Jun 1, 2015 | Alcon |
| NCT02436304 | Phase 3 | Jun 1, 2015 | Alcon |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alcon | For profit | 3 | 3 | 2 | 2015 |
1 organizations
Page 1 / 1